ISSN :2822-5872
Autoimmune Diseases in Patients Hospitalized with COVID-19 [ACH Medical Journal]
ACH Medical Journal. 2023; 2(1): 15-25 | DOI: 10.5505/achmedj.2023.18209

Autoimmune Diseases in Patients Hospitalized with COVID-19

Oguzhan Zengin, Muhammed Fatih Acehan, Burak Göre, Sümeyye Çelik, Hüsamettin Durmuş, Adem Çağlayan, Erbil Çümen, Emra Asfuroğlu Kalkan
Department of Internal Medicine, Ankara City Hospital, Ankara, 06800, Turkey

INTRODUCTION: The aim of this study is to determine the course of COVID 19 in patients with autoimmune diseases (AD), and to investigate the severity of disease, need for intensive care and mortality in these patients.

METHODS: In this study, 125 patients who had COVİD-19 and were diagnosed with autoimmune disease before, were evaluated retrospectively. Comorbidities, demographics, laboratory findings, rates of mortality, intensive care unit admission, administration of immunosuppressive treatments and length of hospital stay were collected.

RESULTS: All patients had a positive SARS-CoV-2 PCR test. The most common autoimmune diseases were rheumatoid arthritis, Hashimoto's thyroiditis and inflammatory bowel diseases.

DISCUSSION AND CONCLUSION: Our results have shown diabetes mellitus (DM), neutrophil lymphocyte ratio and platelet count were found to be an independent risk factor for mortality in patients with AD.

Keywords: Autoimmune diseases, COVID-19, SARS-CoV-2.

Corresponding Author: Burak Göre, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE